Deuterated mitragynine (developmental code name KUR-101) is an atypical μ-opioid receptor agonist and deuterated analogue of mitragynine (found in kratom) which is under development for the treatment of acute pain and opioid-related disorders.; It is taken by mouth. Deumitragynine is said to have analgesic effects. The drug is being developed by ATAI Life Sciences and Kures. As of December 2022, it is in phase 1 clinical trials for acute pain and opioid-related disorders.
See also List of investigational analgesics Mitragyna speciosa (Kratom) Mitragynine Mitragynine pseudoindoxyl 7-Hydroxymitragynine
References
External links Deu-Mitragynine - atai Life Sciences